Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)

NCT03028987 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped LAIV was no longer recommended by ACIP

Conditions

Influenza

Interventions

BIOLOGICAL: Fluzone®
BIOLOGICAL: FluMist®

Sponsor

Stanford University

Collaborators

[object Object]